AG
Artal Group’s Dyne Therapeutics DYN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,516,960
| Closed | -$53.5M | – | 29 |
|
|
2024
Q2 | $53.5M | Sell |
1,516,960
-1,000
| -0.1% | -$35.3K | 1.36% | 8 |
|
|
2024
Q1 | $43.1M | Buy |
1,517,960
+300,000
| +25% | +$8.52M | 1.1% | 12 |
|
|
2023
Q4 | $16.2M | Buy |
1,217,960
+402,875
| +49% | +$5.36M | 0.54% | 24 |
|
|
2023
Q3 | $7.3M | Hold |
815,085
| – | – | 0.31% | 50 |
|
|
2023
Q2 | $9.17M | Buy |
815,085
+282,476
| +53% | +$3.18M | 0.28% | 52 |
|
|
2023
Q1 | $6.14M | Buy |
532,609
+7,609
| +1% | +$87.7K | 0.36% | 57 |
|
|
2022
Q4 | $6.09M | Hold |
525,000
| – | – | 0.34% | 52 |
|
|
2022
Q3 | $6.67M | Hold |
525,000
| – | – | 0.28% | 50 |
|
|
2022
Q2 | $3.61M | Hold |
525,000
| – | – | 0.19% | 72 |
|
|
2022
Q1 | $5.06M | Hold |
525,000
| – | – | 0.21% | 74 |
|
|
2021
Q4 | $6.24M | Hold |
525,000
| – | – | 0.17% | 84 |
|
|
2021
Q3 | $8.53M | Hold |
525,000
| – | – | 0.19% | 82 |
|
|
2021
Q2 | $11M | Hold |
525,000
| – | – | 0.22% | 78 |
|
|
2021
Q1 | $8.15M | Buy |
525,000
+225,000
| +75% | +$3.49M | 0.14% | 95 |
|
|
2020
Q4 | $6.3M | Sell |
300,000
-70,000
| -19% | -$1.47M | 0.14% | 94 |
|
|
2020
Q3 | $7.47M | Buy |
+370,000
| New | +$7.47M | 0.18% | 72 |
|